| domain | peptomyc.com |
| summary | Peptomyc is a company founded by Dr. Laura Soucek (KOL and designer of Omomyc), Dr. Marie-Eve Beaulieu (protein scientist), and developed initially through research at VHIO and ICREA. The current leadership team includes Jesus Martin Garcia (CEO), Laura Soucek (CSO), Manuela Niewel (CMO), and Jrg Klumbis (CFO). The company’s advisory boards consist of experts like Alain Thibault, Alfredo Covelli, Jean-Yves Bonnefoy, Josep Tabernero, Roger Stupp, Enriqueta Felip, Aleix Prat, and Margaret Tempero. Recent news highlights include the commencement of Phase 2 clinical trials for OMO-103 in advanced osteosarcoma, an IND approval for a trial in PDAC patients in collaboration with OHSU Knight Cancer Institute, and an award recognizing their Premis Ciutat de Barcelona 2024 achievement. |
| title | Peptomyc – Developing a Myc inhibitor to treat cancer |
| description | Peptomyc – Developing a Myc inhibitor to treat cancer |
| keywords | cancer, more, treatment, mini, cell, first, board, protein, phase, class, advisory, news, survival, resistance, therapeutic, patients, trial |
| upstreams |
|
| downstreams |
|
| nslookup | A 89.40.80.3 |
| created | 2025-11-11 |
| updated | 2026-01-29 |
| summarized | 2026-01-31 |
|
|